Ulcers Clinical Trials
A listing of Ulcers medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 44 clinical trials
A Multicenter Randomized Double-Blind Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Ulcerative Colitis Who Have Failed Prior Biologic Therapy
The trial will enroll subjects who have had an inadequate response (IR) to prior biologic therapy (bio-IR). The bio-IR population is defined as subjects with documented intolerance or inadequate response to one or more of the approved biologics for UC (infliximab, adalimumab, golimumab, and/or vedolizumab).
- 0 views
- 19 Feb, 2024
- 1 location
A Phase 2 Multi-center Randomized Double-Blind Placebo-Controlled Dose Range Finding Study to Evaluate the Safety Hemodynamic Effects and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects who have Diabetic Foot Ulcer with Peripheral Arterial Disease
After the Pre- Treatment Period, subjects will be randomized to a treatment arm and will receive investigational product (IP) PDA-002 cells or placebo. In the case of bilateral limb ulcers, the treated limb will be the limb that has the lowest qualifying TcPO2 value or ABI/TBI for inclusion. During the …
- 0 views
- 19 Feb, 2024
- 1 location
EVALUATION OF THE VALIANT MONA LSA THORACIC STENT GRAFT SYSTEM IN DESCENDING THORACIC AORTIC ANEURYSMS AND CHRONIC DISSECTIONS
The trial involves an investigational device (not approved by the FDA) for subjects who have an aneurysm (bulge), dissection (tear) or a penetrating ulcer (bubble) of the descending aorta that involve an artery (main blood vessel in your body). The subject must need to have one of their blood vessels …
- 0 views
- 19 Feb, 2024
- 1 location
Profiling and Perturbing the Human Immune System to Understand the Human Immune Network
By studying this IBD cohort, we will be able to interrogate (1) the initial response to immune system perturbations in comparison to other cohorts in the Allen Institute projects; (2) homeostatic equilibrium of these treatments; (3) and loss of homoeostasis. We will enroll patients with Crohns disease or ulcerative colitis. …
- 0 views
- 19 Feb, 2024
- 1 location